Key Highlights: Implications: If completed, the transaction would likely be a strong validation event for mid-sized Indian pharmaceutical businesses that combine branded generics, nu...
Key Highlights: Implications: Rubicon is using the Arinna deal to buy its way into India’s fast‑growing CNS and neuro‑psychiatry market with an immediately revenue‑accretive, chr...
